HOLX · Hologic, Inc.
$75.652026-05-17Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$46
-39.7% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($44 · $49) Analysts Range ($76 · $79) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2022.Q1 | $5.6B | — | 45.4% | 20.2% | $2.0B | −$991MM | $1.1B | 4.7% | — | 28.9% | $7.1B | $8.29 | — |
| 2023.Q1 | $4.9B | -13.7% | 34.8% | 17.8% | $1.4B | $736MM | $2.1B | 7.0% | — | 20.6% | $6.4B | $5.76 | — |
| 2024.Q1 | $4.0B | -17.1% | 17.1% | 18.0% | $565MM | $75MM | $640MM | 7.6% | — | 8.9% | $6.2B | $2.02 | — |
| 2025.Q1 | $4.0B | -0.0% | 22.6% | 19.2% | $735MM | −$49MM | $687MM | 7.1% | — | 11.8% | $6.2B | $3.50 | — |
| 2026.Q1 | $4.1B | 2.4% | 18.0% | 18.0% | $610MM | −$141MM | $469MM | 7.5% | — | 9.8% | $6.2B | $2.41 | 23.0 |
| italics below = DCF projection · 10yr Rev CAGR: 4.2% |
| 2027.Q1 | $4.3B | +3.1% | 18.6% | 18.2% | $648MM | −$196MM | $451MM | 7.5% | $420MM | 10.3% | $6.4B | $2.69 | 28.1 |
| 2028.Q1 | $4.5B | +4.7% | 18.6% | 18.4% | $675MM | −$310MM | $364MM | 7.6% | $315MM | 10.3% | $6.7B | $2.82 | 26.8 |
| 2029.Q1 | $4.7B | +4.9% | 18.5% | 18.6% | $704MM | −$340MM | $364MM | 7.7% | $292MM | 10.2% | $7.1B | $2.96 | 25.6 |
| 2030.Q1 | $4.9B | +4.5% | 18.4% | 18.8% | $731MM | −$328MM | $403MM | 7.8% | $300MM | 10.1% | $7.4B | $3.10 | 24.4 |
| 2031.Q1 | $5.1B | +4.3% | 18.3% | 19.0% | $756MM | −$334MM | $422MM | 8.0% | $291MM | 10.0% | $7.7B | $3.24 | 23.3 |
|
| Term. Yr+ | $6.5B | 4.1% | 18.3% | 20.0% | $954MM | −$299MM | $656MM | 8.6% | $6.7B | 13.1% | — | — | — |
Active scenario IV: $46 (-39.7% vs market)